ProcessIntroductory
What are the dosage recommendations for administering risankizumab to adults weighing 60 to 99 kg?
For adults weighing 60 to 99 kg, the recommended dosage of risankizumab is an initial subcutaneous dose of 150 mg (administered as two 75 mg injections) at weeks 0 and 4, followed by maintenance doses every 12 weeks thereafter.
Key points
- Dosage for adults 60 to 99 kg: 150 mg (two 75 mg injections) at weeks 0 and 4.
- Maintenance doses are given every 12 weeks after the initial doses.
- Risankizumab is used for moderate to severe plaque psoriasis.
Related questions
Mosbys 2021 Nursing Drug Reference by Linda Skidmore-Roth
Unknown
THIRTY-FOURTH EDITION · Elsevier Inc.